These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15124501)

  • 1. Population-based hepatitis C surveillance and treatment in a national managed care organization.
    Shatin D; Schech SD; Patel K; McHutchison JG
    Am J Manag Care; 2004 Apr; 10(4):250-6. PubMed ID: 15124501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of illness of hepatitis C from a managed care organization perspective.
    Armstrong EP; Charland SL
    Curr Med Res Opin; 2004 May; 20(5):671-9. PubMed ID: 15140332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C testing in sexual health services in England, 2002-7: results from sentinel surveillance.
    Tweed E; Brant L; Hurrelle M; Klapper P; Ramsay M;
    Sex Transm Infect; 2010 Apr; 86(2):126-30. PubMed ID: 19858534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
    Morrato EH; Staffa JA
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
    Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral RNA testing in hepatitis C antibody-positive veterans.
    Rongey CA; Kanwal F; Hoang T; Gifford AL; Asch SM
    Am J Prev Med; 2009 Mar; 36(3):235-8. PubMed ID: 19162434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in inappropriate prescribing among elderly veterans.
    Bierman AS; Pugh MJ; Dhalla I; Amuan M; Fincke BG; Rosen A; Berlowitz DR
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):147-61. PubMed ID: 17719517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
    Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms.
    Howden CW; Blume SW; de Lissovoy G
    Am J Manag Care; 2007 Jan; 13(1):37-44. PubMed ID: 17227202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002.
    Stein JD; Ayyagari P; Sloan FA; Lee PP
    Ophthalmology; 2008 Aug; 115(8):1315-9, 1319.e1. PubMed ID: 18321581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
    El-Serag HB; Fitzgerald S; Richardson P
    Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.